NEW YORK, Sept 19 - Human Genome Sciences (Nasdaq: HGSI) stock jumped 9 13/16, or 6.8 percent, to 153 13/16 in mid-morning trading Tuesday following an announcement on  Monday after the close of trading that the company’s board had approved a two-for-one stock split.

Shareholders will receive an additional common share for each share held at close-of-business on Sept. 28. The additional shares will be delivered on or about Oct. 5.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.

Retraction Watch's Ivan Oransky and Adam Marcus report that Harvard Medical School and Brigham and Women's Hospital have recommended that more than 30 papers from a former researcher be retracted.

Thomas Steitz, who won the 2009 chemistry Nobel Prize for his ribosome work, has died, the Washington Post reports.

In PLOS this week: mechanisms for genes implicated in coronary artery disease, rumen microbes and host genetics influence cow methane production, and more.